Miljöpåverkan
Tioguanin
Miljörisk:
Risk för miljöpåverkan av tioguanin kan inte uteslutas då det inte finns tillräckliga ekotoxikologiska data.
Nedbrytning:
Tioguanin är potentiellt persistent.
Bioackumulering:
Tioguanin har låg potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Predicted Environmental Concentration (PEC)
PEC is calculated according to the following formula:
PEC (μg/L) = (A*109 *(100-R))/(365*P*V*D*100) = 1.37*10-6 *A(100-R)
PEC = 1.39 10-4 μg/L
Where:
A = 1,015 kg (total sold amount API in Sweden year 2021, data from IQVIA.)
R = X % removal rate (due to loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation) = 0 if no data is available. R=0
P = number of inhabitants in Sweden = 10*106
V (L/day) = volume of wastewater per capita and day = 200 (ECHA default)(Ref.1)
D = factor for dilution of waste water by surface water flow = 10 (ECHA default)(Ref.1)
Predicted No Effect Concentration (PNEC)
Ecotoxicological Studies
Green alga, Scenedesmus subspicatus
EC50 = 3.4 ug/L (OECD 201)
NOEC = 0.5 ug/L
Water flea, Daphnia magna:
EC50 48h = 16 500, ug/L (OECD 202)
NOEC 48h = 4 900, ug/L
Microorganisms in activated sludge
EC50 3h > 1 000 000, ug/L (OECD 209)
Mouse (oral): LC50 = 160 mg/kg (Ref. 2,3)
A PNEC cannot be calculated because data is not available for all three (algae, crustacean and fish) of the short-term toxicity endpoints.
Environmental risk classification (PEC/PNEC ratio)
Risk of environmental impact of remifentanil cannot be excluded, since there is not sufficient ecotoxicity data available.
Degradation
Results of biological degradation:
Ready Biodegradation = 5% in 28 days (FDA TAD 3.11)
Inherent biodegradation = 68% in 28 days (OECD 302B).
The medicine is potentially persistent.
Results of abiotic degradation:
Hydrolysis
Half-life, pH 7 = 62 days (OECD 111)
Bioaccumulation
Log Kow = - 0.07 (Ref 3)
Since log Kow < 4 at pH 7, the substance has low potential for bioaccumulation.
Excretion (Metabolism)
Only trace amounts of thioguanine are found in the urine. Thioguanine is catabolised to inactive metabolites 6-thioxanthine and 2-amino-6-methythiopurine (MTG). MTG is the principle metabolite excreted in urine (ref 4).
Other Hazard Notation
The compound may be:
-
Acute toxicity (any route of exposure)
-
Respiratory or skin sensitization
-
Germ cell mutagenicity
-
Carcinogenicity
-
Reproductive toxicity
According to SARA 311/312 Hazardous chemical list (Ref 3)
References:
-
[ECHA] European Chemicals Agency. December 2022. Guidance on Information Requirements and Chemical Safety Assessment. Chapter R.16: Environmental exposure assessment (version 3.0)
-
British Pharmacopoeia, Safety Data Sheet according to 1907/2006/EC, Article 31, Allopurinol, Revision 02.12.2013
-
Aspen Global Incorporated, Safety Data Sheet, Tiogaunine 40 mg tablets, version 2.0, revision 05.01.2018
-
Brox LW, et al, Cancer Chemother Pharmacol 6: 35-38, 1981.